Vegf Polymorphism May Be Associated With Overall Survival In Lapatinib-Treated Breast Cancer Patients With Brain Metastases.

Colin F. Spraggs,Li Li,Linda P. Briley, Alaknanda Joshi, Allison M. Florance,Karen King,Laura R. Parham

JOURNAL OF CLINICAL ONCOLOGY（2012）

引用 0|浏览12

暂无评分

摘要

10532 Background: Lapatinib is a dual HER2/EGFR tyrosine kinase inhibitor (TKI) approved in combination with capecitabine or letrozole for patients with HER2+ metastatic breast cancer (MBC). Consis...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要